AKT1 and rheumatoid arthritis: Phosphoinositide 3-kinase (PI3K)/Akt and Mitogen-activated protein kinase (MAPK) are involved in the control of FLS activity in RA, including matrix metalloproteinases (MMP) expression, synoviocyte growth and survival, and are the subject of therapeutic intervention in RA [169].